HSAL3 was highly expressed in HCC and correlated with poor prognosis, it was identified as an uncharacterized SE-driven oncogenic lncRNA which was activated by transcription factors HCFC1 and HSF1 via its SE. The gene discussed is HEXIM2-AS2; the disease is hepatocellular carcinoma.